Target intelligence / Profile preview

Vacuolar-type H+-ATPase complex (v-ATPase)

Target
v-ATPase
Molecular classification
Enzyme, Transporter, Proton pump, Multi-subunit complex
01

Overview

The Vacuolar-type H+-ATPase (v-ATPase) complex is a highly conserved, multi-subunit molecular machine that functions as an ATP-driven proton pump across endomembrane systems, most notably the lysosome (UniProt: P38606). By maintaining an acidic luminal pH, the v-ATPase enables the optimal activity of lysosomal enzymes and facilitates essential processes such as receptor-mediated endocytosis, protein sorting, and autophagy. Beyond its role as a pump, the complex serves as a scaffold for the nutrient-sensing machinery, specifically the mTORC1 pathway, linking cellular metabolic state to growth signals (PMID: 21642988). In pathology, v-ATPase dysregulation is linked to cancer progression, where it acidifies the extracellular space to promote metastasis, and to neurodegenerative diseases where lysosomal dysfunction leads to protein aggregation (PMID: 24441444). While potent inhibitors like bafilomycin exist, their clinical utility is currently limited by toxicity, prompting research into isoform-specific inhibitors to improve therapeutic windows (PMID: 15687169).

Other names
V-type ATPaseVacuolar proton pumpH+-transporting ATPaseV-type H+-transporting ATPaseLysosomal proton pump
02

Mechanism of action

Inhibition of ATP-dependent proton translocation across the lysosomal membrane, leading to neutralization of lysosomal pH and disruption of downstream degradative and signaling pathways (PMID: 15687169).

03

Biological functions

Lysosomal acidificationpH homeostasisNutrient sensingProtein degradationVesicle traffickingAutophagymTORC1 activation
04

Disease associations

CancerOsteoporosisNeurodegenerative diseaseViral infectionRenal tubular acidosis
05

Safety considerations

Systemic toxicityDisruption of cellular homeostasisUbiquitous expression leading to off-target effectsImpaired bone remodeling
06

Interacting drugs

Bafilomycin A1

6 more in the full profile.

07

Biomarkers

Lysosomal pHLC3-II levelsp-S6K1 (mTORC1 activity)Cathepsin D activity

Beyond the preview

Go deeper on Vacuolar-type H+-ATPase complex (v-ATPase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolar-type H+-ATPase complex (v-ATPase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call